Cargando…

Complement C7 (C7), a Potential Tumor Suppressor, Is an Immune-Related Prognostic Biomarker in Prostate Cancer (PC)

Objectives: Prostate cancer (PC) is the second most frequent tumor in men, which has a high recurrence rate and poor prognosis. Therefore, this study aimed to identify novel prognostic biomarkers and therapeutic targets for immunotherapy and small molecule drugs for PC treatment. Materials and Metho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Zhao, Yan, Xin, Du, Guo-Wei, Tuoheti, Kurerban, Bai, Xiao-Jie, Wu, Hua-Hui, Zhang, Ren-Jie, Xiao, Guan-Fa, Liu, Tong-Zu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477933/ https://www.ncbi.nlm.nih.gov/pubmed/32984006 http://dx.doi.org/10.3389/fonc.2020.01532

Ejemplares similares

Construction and Validation of an Autophagy-Related Prognostic Signature and a Nomogram for Bladder Cancer
por: Yan, Xin, et al.
Publicado: (2021)

GNRH1 and LTB4R might be novel immune-related prognostic biomarkers in clear cell renal cell carcinoma (ccRCC)
por: Wu, Hua-Hui, et al.
Publicado: (2021)

Identification of transforming growth factor beta induced (TGFBI) as an immune-related prognostic factor in clear cell renal cell carcinoma (ccRCC)
por: Du, Guo-Wei, et al.
Publicado: (2020)

Tumor Suppressor Par-4 Regulates Complement Factor C3 and Obesity
por: Araujo, Nathalia, et al.
Publicado: (2022)

Complement component 7 (C7), a potential tumor suppressor, is correlated with tumor progression and prognosis
por: Ying, Lisha, et al.
Publicado: (2016)

High Expression of Complement Component C7 Indicates Poor Prognosis of Breast Cancer and Is Insensitive to Taxane-Anthracycline Chemotherapy
por: Zhang, Huikun, et al.
Publicado: (2021)

The Bioinformatics-Based Analysis Identifies 7 Immune-Related Genes as Prognostic Biomarkers for Colon Cancer
por: Pan, Jie, et al.
Publicado: (2021)

Tumor Suppressor miR-184 Enhances Chemosensitivity by Directly Inhibiting SLC7A5 in Retinoblastoma
por: He, Tian-Geng, et al.
Publicado: (2019)

Two Novel Mutations in the C7 gene in a Korean Patient with Complement C7 Deficiency
por: Ki, Chang-Seok, et al.
Publicado: (2005)

Complement C1q (C1qA, C1qB, and C1qC) May Be a Potential Prognostic Factor and an Index of Tumor Microenvironment Remodeling in Osteosarcoma
por: Chen, Long-hao, et al.
Publicado: (2021)

Prognostic and Predictive Value of Liquid Biopsy-Derived Androgen Receptor Variant 7 (AR-V7) in Prostate Cancer: A Systematic Review and Meta-Analysis
por: Khan, Tanzila, et al.
Publicado: (2022)

MicroRNA-92b targets tumor suppressor gene FBXW7 in glioblastoma
por: Grafals-Ruiz, Nilmary, et al.
Publicado: (2023)

Commentary: Meta-Analyses Reporting the Prognostic Value of Androgen Receptor Splice Variant 7 in Castration-Resistant Prostate Cancer
por: Kattan, Michael W., et al.
Publicado: (2020)

CDK7 is a prognostic biomarker for non-small cell lung cancer
por: Kuempers, Christiane, et al.
Publicado: (2022)

Complement C1q Activates Tumor Suppressor WWOX to Induce Apoptosis in Prostate Cancer Cells
por: Hong, Qunying, et al.
Publicado: (2009)

Selenium Biomarkers in Prostate Cancer Cell Lines and Influence of Selenium on Invasive Potential of PC3 Cells
por: Hendrickx, Wouter, et al.
Publicado: (2013)

KDM5c Promotes Colon Cancer Cell Proliferation Through the FBXW7-c-Jun Regulatory Axis
por: Lin, Haishan, et al.
Publicado: (2020)

KDM5C Represses FASN-Mediated Lipid Metabolism to Exert Tumor Suppressor Activity in Intrahepatic Cholangiocarcinoma
por: Zhang, Bo, et al.
Publicado: (2020)

SIRT7 Is a Prognostic Biomarker Associated With Immune Infiltration in Luminal Breast Cancer
por: Huo, Qin, et al.
Publicado: (2020)

The Prognostic Value of the C-reactive Protein/Prognostic Nutritional Index Ratio in Stage III and IV Laryngeal Cancer Patients Treated with Radiotherapy
por: Fu, Jie, et al.
Publicado: (2019)

Systematic Pan-Cancer Analysis of KIF23 and a Prediction Model Based on KIF23 in Clear Cell Renal Cell Carcinoma (ccRCC)
por: Bai, Xiaojie, et al.
Publicado: (2021)

Meta-analysis of the prognostic value of C-C chemokine receptor type 7 in patients with solid tumors
por: Zu, Guangchen, et al.
Publicado: (2019)

microRNA-126 Is a Tumor Suppressor of Granulosa Cell Tumor Mediated by Its Host Gene EGFL7
por: Tu, Jiajie, et al.
Publicado: (2019)

TFAP2C-Mediated lncRNA PCAT1 Inhibits Ferroptosis in Docetaxel-Resistant Prostate Cancer Through c-Myc/miR-25-3p/SLC7A11 Signaling
por: Jiang, Xingkang, et al.
Publicado: (2022)

MiR-21 and let-7 cooperation in the regulation of lung cancer
por: Bai, Jinquan, et al.
Publicado: (2022)

Prognostic Value of Androgen Receptor Splice Variant 7 in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis
por: Wang, Jiaxin, et al.
Publicado: (2020)

Xeroderma Pigmentosum Complementation Group C (XPC): Emerging Roles in Non-Dermatologic Malignancies
por: Nasrallah, Nawar Al, et al.
Publicado: (2022)

Complement Factor C7 Contributes to Lung Immunopathology Caused by Mycobacterium tuberculosis
por: Welsh, Kerry J., et al.
Publicado: (2012)

My Microsoft Windows 7 PC
por: Murray, Katherine
Publicado: (2012)

Clusters of Circulating let-7 Family Tumor Suppressors Are Associated with Clinical Characteristics of Chronic Hepatitis C
por: Tsai, Yi-Shan, et al.
Publicado: (2020)

The Role of miR-640: A Potential Suppressor in Breast Cancer via Wnt7b/β-catenin Signaling Pathway
por: Tang, Chun, et al.
Publicado: (2021)

A Comprehensive Pan-Cancer Analysis of the Tumorigenic Role of Matrix Metallopeptidase 7 (MMP7) Across Human Cancers
por: Meng, Nana, et al.
Publicado: (2022)

Characterization of 7-Methylguanosine Identified Biochemical Recurrence and Tumor Immune Microenvironment in Prostate Cancer
por: Xin, Sheng, et al.
Publicado: (2022)

Prognostic influence of PD-1/PD-L1 suppressors in combination with chemotherapeutic agents for non-small cell pulmonary carcinoma: system review and meta-analysis
por: Shen, Min, et al.
Publicado: (2023)

Characterization of Synonymous BRCA1:c.132C>T as a Pathogenic Variant
por: Li, Jun, et al.
Publicado: (2022)

A Novel Immune-Related Prognostic Biomarker and Target Associated With Malignant Progression of Glioma
por: Zhang, Yu, et al.
Publicado: (2021)

Dysregulation of FBW7 in malignant lymphoproliferative disorders
por: Wan, Xin, et al.
Publicado: (2022)

The Neurogenic Compound P7C3 Regulates the Aerobic Glycolysis by Targeting Phosphoglycerate Kinase 1 in Glioma
por: Chen, Wenjin, et al.
Publicado: (2021)

Complement C7 is a novel risk gene for Alzheimer's disease in Han Chinese
por: Zhang, Deng-Feng, et al.
Publicado: (2019)

Loss of the Fbw7 tumor suppressor rewires cholesterol metabolism in cancer cells leading to activation of the PI3K-AKT signalling axis
por: Bengoechea-Alonso, Maria T., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_slp8spaspqdkb04fa78pot6387